Diffuse large B cell lymphoma is the most common subtype of non-Hodgkin lymphoma , comprising approximately one-third of all cases of NHL. 1 Although the addition of rituximab to conventional chemotherapy has improved the outcomes for patients with DLBCL, a significant number still relapse and eventually die from lymphoma.
http://ift.tt/1KlZKCH
http://ift.tt/1KlZKCH
No comments:
Post a Comment